-transparent.png){kind=logo}
Clinical isolates of Shigella spp. were examined for their susceptibility to human serum. The susceptibility of the strains to immune and nonimmune human serum was dependent upon the size of the bacterial inoculum and the concentration of serum. There were differences among Shigella spp. in susceptibility to human serum: S. sonnei strains were the least susceptible, strains of S. boydii and S. flexneri serotype 6 were intermediate, and those of S. flexneri other than serotype 6 and S. dysenteriae were the most susceptible. Experiments in which heat-treated (56 degrees C for 30 min, or 50 degrees C for 20 min) serum was used, and analysis of activation of complement by lipopolysaccharides (LPS) from each Shigella sp., suggested that LPS composition, especially the O antigen polysaccharide chains, contributes to the differences among Shigella spp. in susceptibility to human serum.
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
January 1990,
Acta microbiologica Polonica,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
March 1996,
Helicobacter,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
February 1985,
The Journal of infectious diseases,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
July 1986,
Journal of dental research,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
July 1979,
The Journal of infectious diseases,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
January 1990,
Acta microbiologica Polonica,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
January 1982,
Methods and findings in experimental and clinical pharmacology,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
June 2020,
High-throughput,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
July 1992,
FEMS microbiology immunology,
N Okamura, and
R Nakaya, and
K Suzuki, and
S Kondo, and
K Hisatsune, and
Y Imagawa, and
H Sagara, and
Y Matsubara
March 2015,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
